Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adenocarcinoma
71%
Adenocarcinoma in Situ
40%
Angiogenesis
22%
Angiosarcoma
18%
Biopsy Technique
57%
Breast Carcinoma
17%
Cadherin
13%
Cancer
72%
Carcinoma
22%
Carcinosarcoma
13%
Clear Cell Renal Cell Carcinoma
22%
Connective Tissue Cancer
13%
Cytopathology
40%
Cytotechnology
37%
DNA Microarray
13%
Effusion
31%
Endometrium Carcinoma
36%
Epithelial Cell
15%
Epithelioma
13%
Fallopian Tube
33%
False Negative Result
47%
Fine-Needle Aspiration
13%
Gynecologic Pathology
13%
Immunohistochemistry
18%
Kidney Metastasis
18%
Lung
13%
Lymph Node
19%
Malignant Neoplasm
34%
Metastatic Carcinoma
78%
Microvessel
17%
Natural Killer Cell Lymphoma
13%
Needle Biopsy
13%
Neoplasm
100%
Ovarian Cancer
81%
Papanicolaou Stain
54%
Pathologist
16%
Primary Tumor
20%
Progesterone Receptor
18%
Programmed Death-Ligand 1
13%
Protein P53
21%
Receptor Expression
13%
Relaxin
13%
Retrospective Study
13%
Serous Carcinoma
46%
Transcription Factor
13%
Tumor
71%
Tumor Infiltrating Lymphocyte
13%
Uterine Cancer
54%
Vasculotropin
21%
Wart Virus
13%
Keyphrases
American Society
27%
Angiogenesis
19%
Apologizing
27%
ASC-H
15%
Biopsy-proven
40%
Body Fluids
27%
Carcinoma
16%
Carcinoma in Situ
40%
Cellular Origin
16%
Cervical Cytology
17%
Clinical Significance
15%
Cytopathology
40%
Effusion
27%
Endometrial Cancer
54%
Endometrial Carcinoma
20%
EphA2
27%
Fallopian Tube
29%
High-grade Serous Carcinoma
56%
High-grade Serous Ovarian Cancer (HGSOC)
45%
High-risk Human Papillomavirus (HR-HPV)
28%
Human Papillomavirus Genotypes
40%
Immunohistochemical Study
27%
Inconvenience
27%
Interobserver Agreement
40%
Invasive Adenocarcinoma
40%
Kidney
16%
Malignancy
22%
Metastasizing
15%
Metastatic Ovarian Cancer
18%
Metastatic Renal Cell Carcinoma (mRCC)
16%
Metastatic Tumor
23%
Mouse Model
28%
Non-neoplastic Tissue
17%
Ovarian Cancer
34%
Overexpression
31%
Pap Test
27%
Papanicolaou Test
44%
PAX2
54%
PAX8
40%
Peritoneal Metastasis
16%
Poor Outcome
15%
Primary Tumor
21%
Progesterone Receptor
16%
Regret
27%
Renal Cell Carcinoma
19%
Retrospective Analysis
40%
Serous Ovarian Cancer
15%
Single Institution
30%
Squamous Cell Carcinoma (SqCC)
21%
Tumor
76%